Tympanometry: Middle Ear Assessment, Jerger Classification & Clinical Interpretation — Cost, Top Hospitals & Success Rates | MyMedicPlus

Tympanometry is a standardised objective audiological test that measures the acoustic immittance (compliance and impedance) of the middle ear system as a function of air pressure applied to the sealed ear canal. It provides direct, quantifiable information about middle ear pressure, tympanic membrane mobility, and Eustachian tube function — clinical data that cannot be reliably obtained by otoscopy alone.

The test was first described clinically by Otto Metz in 1946, who demonstrated that measuring the acoustic impedance of the ear could identify middle ear disorders. The landmark contribution of James Jerger in 1970 established the classification system for tympanogram shapes (Types A, B, C) that remains in universal clinical use today.

During tympanometry, a probe containing a 226 Hz tone generator, a microphone, and a pressure pump is inserted into the sealed ear canal. The system sweeps air pressure from approximately +200 daPa to –400 daPa, recording the proportion of probe-tone energy reflected back from the tympanic membrane at each pressure point. The result is a tympanogram — a graphical plot of compliance (in millilitres or mmho) against ear canal pressure (in daPa). A normally functioning middle ear produces a smooth, peaked tympanogram at or near 0 daPa (atmospheric pressure), reflecting maximal tympanic membrane compliance when the pressure across the membrane is equalised.

Tympanometry is performed routinely in audiology clinics, ENT departments, GP practices, and community health screening programmes. Its key strengths are that it is objective, rapid (30 seconds per ear), non-invasive, radiation-free, and reproducible. It is an indispensable complement to pure-tone audiometry, otoscopy, and acoustic reflex testing in the full audiological assessment battery. For neonates and infants under 6 months, a 1000 Hz probe tone is used instead of 226 Hz because the highly compliant neonatal ear canal wall absorbs the low-frequency probe tone before it can interact with the middle ear, producing spuriously normal-appearing tympanograms in the presence of genuine pathology.

Tympanometry is indicated for objective evaluation of a wide range of conditions affecting the middle ear and Eustachian tube. It does not "treat" these conditions but provides the diagnostic precision needed to guide treatment decisions:

• Otitis media with effusion (OME / "glue ear"): The most common clinical application in paediatric audiology. A Type B tympanogram with normal ear canal volume strongly suggests the presence of middle ear fluid. Tympanometry guides decisions about watchful waiting versus grommet (ventilation tube) insertion.
• Acute otitis media (AOM): Tympanometry demonstrates reduced compliance and shifted tympanometric peak, confirming clinical diagnosis and supporting antibiotic prescribing decisions.
• Tympanic membrane perforation: Produces a Type B tympanogram with an abnormally large ear canal volume (above 2.0 mL in adults). This pattern distinguishes perforation from effusion — a critical clinical distinction.
• Eustachian tube dysfunction: A Type C tympanogram (peak at negative pressure, typically –100 to –200 daPa) indicates impaired Eustachian tube equalisation, often preceding effusion development.
• Ossicular chain discontinuity: Produces a Type Ad tympanogram — an abnormally high, broad peak exceeding the measurement scale — suggesting hypercompliance due to disrupted ossicular coupling.
• Otosclerosis screening: Produces a Type As (shallow) tympanogram with reduced peak compliance, reflecting stiffness of the ossicular chain. Acoustic reflex testing frequently shows absent reflexes in otosclerosis.
• Cholesteatoma surveillance: Post-surgical monitoring and screening in patients with known or suspected cholesteatoma; tympanometry helps detect recurrent retraction pockets or effusion.
• Neonatal hearing screening follow-up: 1000 Hz tympanometry is used in the diagnostic test battery following a refer result on newborn OAE or ABR screening, to assess middle ear status before committing to audiological diagnosis.

Tympanometry is appropriate for patients of all ages when middle ear status needs objective assessment, but specific considerations apply by age group and clinical context:

• Adults and children over 6 months: Standard 226 Hz single-frequency tympanometry is the appropriate first-line test. Patients require no specific preparation beyond sitting still. The procedure is painless and takes under one minute per ear, making it suitable for virtually all cooperative patients.
• Infants under 6 months: Standard 226 Hz tympanometry is unreliable in this age group due to the high compliance of the neonatal ear canal wall. A 1000 Hz probe tone is required. The resulting tympanogram has a different morphology from adult norms; specialised interpretation guidelines (Alaerts et al., 2007) apply. Testing is best performed during natural sleep or a quiet alert state.
• Neonatal intensive care graduates and high-risk neonates: 1000 Hz tympanometry combined with click-evoked ABR forms the standard audiological assessment battery for neonates at risk of auditory neuropathy or structural ear pathology.
• Contraindications: Active otorrhoea (discharge from the ear canal) contraindicates probe insertion due to infection risk and potential equipment contamination. Severe ear canal stenosis or atresia may prevent adequate probe seal. Patients with significant pain on otoscopy should be examined clinically before tympanometry is attempted.
• Probe seal requirements: An airtight probe seal is essential for valid tympanometry. Excessive ear canal hair, wax impaction (cerumen), or a probe tip that is too small or too large for the canal will prevent adequate sealing and produce artefactual results. Cerumen removal before tympanometry is recommended when occlusion is significant.
• Cooperation requirements: Patients must remain still, breathe normally (not swallow or yawn during measurement), and not vocalise. Most adults and older children cooperate readily; young toddlers may require distraction or parental assistance.

Tympanometry encompasses a family of related techniques differing in probe-tone frequency, measurement bandwidth, and the additional parameters assessed. Each variant provides distinct clinical information:

• Single-frequency tympanometry at 226 Hz: The clinical standard for adults and children over 6 months. Produces the classic tympanogram plot of compliance vs. pressure, classified according to the Jerger system. Type A (normal peak near 0 daPa), Type B (flat, no peak — effusion, perforation, or impacted cerumen), and Type C (peak at negative pressure — Eustachian tube dysfunction) form the foundational interpretive framework.
• High-frequency tympanometry at 1000 Hz: Mandatory for neonates and infants under 6 months. The 1000 Hz tone is less susceptible to artifactual absorption by the compliant neonatal ear canal wall. Pass and refer criteria differ from 226 Hz norms; a notched (double-peaked) tympanogram at 1000 Hz in neonates suggests normal middle ear function rather than pathology — a distinction critical to avoid misdiagnosis.
• Multifrequency tympanometry: Sweeps through a range of probe-tone frequencies (226–2000 Hz) at a fixed pressure, generating a three-dimensional data set. Enables calculation of resonant frequency of the middle ear system, providing differential diagnostic information about ossicular mass (increased compliance at low frequencies, suggesting disarticulation) versus stiffness (reduced compliance at low frequencies, suggesting otosclerosis or adhesive otitis).
• Wideband acoustic immittance (WAI): A newer technique that simultaneously measures energy reflectance across a broad frequency range (0.2–8 kHz) using a click or chirp stimulus. WAI provides more detailed characterisation of middle ear mechanics than single-frequency tympanometry and is particularly sensitive to early-stage OME, ossicular fixation, and superior semicircular canal dehiscence.
• Acoustic reflex testing (ART): Performed immediately after tympanometry using the same probe. Ipsilateral reflex: the probe tone and the reflex-eliciting stimulus are in the same ear. Contralateral reflex: stimulus in one ear, probe measuring stapedial contraction in the other. Absent reflexes localise to conductive or sensorineural hearing loss, auditory neuropathy, or facial nerve pathology.

Tympanometry provides a range of clinical benefits that have established it as an indispensable component of the audiological assessment battery:

• Objective and quantifiable: Unlike otoscopy, which depends on operator skill and subjective interpretation, tympanometry produces numerical data (peak compliance, peak pressure, ear canal volume, tympanometric width) that can be compared with normative values and tracked longitudinally across visits.
• Non-invasive and radiation-free: The test uses a low-level probe tone and air pressure only. No needles, contrast agents, radiation, or sedation are required. It is safe for any age group, including premature neonates.
• Rapid and well-tolerated: Each ear is tested in approximately 30 seconds. The test causes no pain; patients experience only mild pressure changes in the ear canal. It is routinely tolerated even by uncooperative young children with appropriate technique.
• Distinguishes middle ear pathology subtypes: Tympanometry reliably differentiates OME (Type B with normal canal volume) from tympanic membrane perforation (Type B with large canal volume), and Eustachian tube dysfunction (Type C) from normal middle ear function (Type A) — distinctions not reliably made by otoscopy alone in many clinical settings.
• Guides treatment decisions: Results directly inform watchful waiting vs. grommet insertion in OME, antibiotic prescribing in AOM, and referral thresholds for ENT surgery. In neonatal hearing screening, tympanometry prevents misclassification of conductive hearing loss as sensorineural.
• Monitors treatment response: Sequential tympanometry before and after ventilation tube insertion, medical treatment of OME, or Eustachian tube intervention provides objective evidence of middle ear pressure normalisation.
• Cost-effective: Tympanometry equipment is relatively low-cost, portable, and easily used in community and primary care settings, enabling widespread, accessible middle ear screening without specialist referral for initial assessment.

Tympanometry has an excellent safety profile, but clinical teams should be aware of the following limitations and sources of error to interpret results correctly:

• Ear canal discomfort: The probe tip must create an airtight seal in the ear canal. Incorrect probe sizing or excessive insertion depth can cause mild discomfort or ear canal abrasion. Proper technique minimises this risk.
• Probe seal failure: The most common technical error — an inadequate seal produces artefactual results. Signals include flat tympanograms with abnormally small canal volumes (near 0 mL) or erratic pressure traces. Cerumen impaction, collapsed canals, or poorly sized probe tips cause seal failure.
• Misinterpretation in neonates: Using 226 Hz tympanometry in infants under 6 months produces unreliable results. A normal-appearing Type A tympanogram may mask genuine middle ear pathology. This error has significant clinical consequences if it leads to false reassurance in the neonatal hearing screening pathway.
• Cross-infection risk: Probe tips that contact the ear canal must be either single-use disposable or thoroughly decontaminated between patients using validated protocols. Inadequate decontamination risks transmission of bacterial and viral pathogens including MRSA. Standard infection control procedures in well-run audiology departments reduce this risk to negligible levels.
• Context-dependent interpretation: Tympanogram results must always be interpreted alongside otoscopic findings, pure-tone audiometry, acoustic reflex results, and clinical history. An isolated Type B tympanogram, for example, may reflect effusion, perforation, cerumen, or probe seal failure — clinical context is essential to distinguish these.
• Equipment calibration dependency: Tympanometers require regular calibration verification (at minimum annually, ideally daily) using a reference cavity. Uncalibrated equipment produces systematically inaccurate compliance and pressure values.
• Patient movement artefact: Swallowing, jaw movement, vocalisation, or crying during measurement introduces artefactual peaks or fluctuations. Repeating measurements during movement-free windows is required for valid results.

Structured repeat tympanometry is an important component of the management pathway for several middle ear conditions:

• Otitis media with effusion (OME) watchful waiting: National guidelines (NICE NG98, AAO-HNS guidelines) recommend a watchful waiting period of 3 months before surgical referral in children with OME, during which repeat tympanometry at 6–8 week intervals documents whether effusion resolves spontaneously. Persistent bilateral Type B tympanograms at 3 months in a child with significant hearing loss trigger referral for grommet insertion.
• Post-grommet (ventilation tube) assessment: Tympanometry is performed at 6–8 weeks post-insertion to confirm tube patency. A Type B tympanogram with a large ear canal volume confirms the tube is open and functioning. Flat tympanogram with normal canal volume suggests blocked or extruded tube.
• Post-AOM resolution monitoring: Repeat tympanometry at 6–8 weeks after acute otitis media confirms resolution of effusion or identifies the minority of children who develop persistent OME requiring further management.
• Neonatal follow-up pathway: Infants referred from newborn hearing screening receive 1000 Hz tympanometry as part of the diagnostic audiology assessment at 2–3 months corrected age. Results inform whether hearing loss is conductive or sensorineural, directly affecting diagnostic and habilitation pathways.
• High-risk population annual screening: Children with Down syndrome, cleft palate, craniofacial syndromes, or immunodeficiency — all carrying higher rates of OME — benefit from annual tympanometry and audiological review even in the absence of acute symptoms.
• Pre-operative assessment for ossiculoplasty or stapedectomy: Pre-surgical multifrequency tympanometry and acoustic reflex testing help characterise the ossicular chain integrity and mass/stiffness ratio, supporting surgical planning and prognostication.

The cost of tympanometry varies based on clinical setting, bundling with other assessments, and geographic location:

• Clinical setting: Tympanometry is included routinely in NHS audiology appointments in the United Kingdom at no direct cost to patients. In private or specialist ENT settings, it may be charged separately or bundled within a comprehensive hearing assessment fee.
• Bundling with full audiological assessment: In most clinical settings, tympanometry is performed alongside otoscopy, pure-tone audiometry (PTA), and acoustic reflex testing as part of a complete hearing assessment. The combined appointment fee (typically $150–$350 in the United States) covers all components rather than charging for tympanometry in isolation.
• Equipment sophistication: Standard single-frequency tympanometry equipment is widely available and affordable; the per-test cost attributable to equipment amortisation is low. Wideband acoustic immittance (WAI) systems are significantly more expensive, limiting their availability to specialist centres, and may carry higher per-test costs.
• Neonatal specialist testing: 1000 Hz tympanometry for neonates requires specific software and calibration, and is typically only available in specialist audiology departments or neonatal intensive care-linked services. Appointment fees may be higher than standard paediatric audiology.
• Repeat testing burden: In OME management, children may require multiple tympanometry assessments over 3–6 months. Under publicly funded healthcare systems (NHS, Medicare equivalents), these are covered. In insurance-based systems, prior authorisation may be required for multiple sequential assessments.
• Country of testing: United Kingdom (NHS): included in NHS audiology referral at no charge. United States: $50–$150 per test if billed separately; often bundled within comprehensive hearing evaluation at $250–$400. India: INR 500–1,500 (approximately $6–$18) in private ENT clinics; included in government health facility appointments.

While tympanometry is the gold standard objective middle ear test, several alternative and complementary assessment tools are used in clinical practice:

• Otoscopy with pneumatoscopy (Siegle pneumatic speculum): Direct visualisation of the tympanic membrane combined with application of gentle positive and negative pressure. An immobile tympanic membrane under pneumatic force strongly suggests middle ear effusion. Sensitivity and specificity depend heavily on operator skill and experience; tympanometry provides superior objectivity.
• Acoustic otoscope (reflectometry — EarCheck): Handheld device that uses spectral gradient analysis of sound reflected from the tympanic membrane to detect middle ear fluid. Appropriate for primary care screening; lacks the quantitative detail of formal tympanometry. Useful in resource-limited settings or as a rapid screening adjunct in general practice.
• Pure-tone audiometry (PTA): Measures hearing thresholds at multiple frequencies; identifies conductive hearing loss (air-bone gap) that indicates middle ear pathology. Complements tympanometry but does not directly measure middle ear pressure or compliance. Both tests are routinely performed together for a complete assessment.
• Video-otoscopy: High-resolution digital otoscope with image or video capture. Improves tympanic membrane visualisation, enables documentation, and facilitates remote consultation and telemedicine review. Does not provide acoustic impedance data.
• CT scan of temporal bones: Provides detailed structural imaging of the middle ear and mastoid. Indicated for suspected cholesteatoma, ossicular chain anomaly, temporal bone fracture, or congenital malformation. Involves radiation exposure; reserved for cases where structural diagnosis is needed beyond what tympanometry and audiometry provide.
• MRI of the temporal bones: Superior soft-tissue resolution compared with CT; used for acoustic neuroma evaluation, labyrinthitis, and non-echo-planar DWI sequences for cholesteatoma detection. No radiation; not a first-line middle ear test.
• Electrocochleography (ECoG): Specialised electrophysiological test measuring cochlear and auditory nerve electrical potentials; used for Meniere disease diagnosis. Not a middle ear assessment tool but part of the extended audiological battery.